Skip to main content
NCBI home page
Protein & Cell logoLink to Protein & Cell
. 2010 Nov 9;1(10):927–934. doi: 10.1007/s13238-010-0114-y

A transcription assay for EWS oncoproteins in Xenopus oocytes

King Pan Ng 1, Felix Cheung 1, Kevin A W Lee 1,✉
PMCID: PMC4875118  PMID: 21204019

Abstract

Aberrant chromosomal fusion of the Ewing’s sarcoma oncogene (EWS) to several different cellular partners produces the Ewing’s family of oncoproteins (EWS-fusion-proteins, EFPs) and associated tumors (EFTs). EFPs are potent transcriptional activators, dependent on the N-terminal region of EWS (the EWS-activation-domain, EAD) and this function is thought to be central to EFT oncogenesis and maintenance. Thus EFPs are promising therapeutic targets, but detailed molecular studies will be pivotal for exploring this potential. Such studies have so far largely been restricted to intact mammalian cells while recent evidence has indicated that a mammalian cell-free transcription system may not support bona fide EAD function. Therefore, the lack of manipulatable assays for the EAD presents a significant barrier to progress. Using Xenopus laevis oocytes we describe a plasmid-based micro-injection assay that supports efficient, bona fide EAD transcriptional activity and hence provides a new vehicle for molecular dissection of the EAD.

Keywords: EWS/ATF1, Ewing’s sarcoma, microinjection, Xenopus oocytes, transcription, EWS-activation domain

References

  1. Arvand A., Denny C.T. Biology of EWS/ETS fusions in Ewing’s family tumors. Oncogene. 2001;20:5747–5754. doi: 10.1038/sj.onc.1204598. [DOI] [PubMed] [Google Scholar]
  2. Azuma M., Embree L.J., Sabaawy H., Hickstein D.D. Ewing sarcoma protein Ewsr1 maintains mitotic integrity and proneural cell survival in the zebra fish embryo. PLoS ONE. 2007;10:e979. doi: 10.1371/journal.pone.0000979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bachmaier R., Aryee D.N.T., Jug G., Kauer M., Kreppel M., Lee K. A.W., Kovar H. O-GlcNAcylation is involved in the transcriptional activity of EWS-FLI1 in Ewing’s sarcoma. Oncogene. 2009;28:1280–1284. doi: 10.1038/onc.2008.484. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brown A.D., Lopez-Terrada D., Denny C.T., Lee K.A.W. Promoters containing ATF-binding sites are de-regulated in tumour-derived cell lines that express the EWS/ATF1 oncogene. Oncogene. 1995;10:1749–1756. [PubMed] [Google Scholar]
  5. Carey M., Kolman J., Katz D.A., Gradoville L., Barberis L., Miller G. Transcriptional synergy by the Epstein-Barr virus transactivator ZEBRA. J Virol. 1992;66:4803–4813. doi: 10.1128/jvi.66.8.4803-4813.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Davis I.J., Kim J.J., Ozsolak F., Widlund H.R., Rozenblatt-Rosen O., Granter S.R., Du J., Fletcher J.A., Denny C.T., Lessnick S.L., et al. Oncogenic MITF dysregulation in clear cell sarcoma: defining the MiT family of human cancers. Cancer Cell. 2006;9:473–484. doi: 10.1016/j.ccr.2006.04.021. [DOI] [PubMed] [Google Scholar]
  7. Feng L., Lee K.A.W. A repetitive element containing a critical tyrosine residue is required for transcriptional activation by the EWS/ATF1 oncogene. Oncogene. 2001;20:4161–4168. doi: 10.1038/sj.onc.1204522. [DOI] [PubMed] [Google Scholar]
  8. Goldin A.L. Maintenance of Xenopus laevis and oocyte injection. Methods Enzymol. 1992;207:266–279. doi: 10.1016/0076-6879(92)07017-I. [DOI] [PubMed] [Google Scholar]
  9. Guille M. Microinjection into Xenopus oocytes and embryos. Methods Mol Biol. 1999;127:111–123. doi: 10.1385/1-59259-678-9:111. [DOI] [PubMed] [Google Scholar]
  10. Gurdon, J.B., and Wakefield, L. (1986). Microinjection of Amphibian Oocytes and Eggs for the Analysis of Transcription. Microinjection and Organelle Transplantation Techniques. Academic Press Inc., pp 269–299.
  11. Gurdon J.B., Wickens M.P. The use of Xenopus oocytes for the expression of cloned genes. Methods Enzymol. 1983;101:370–386. doi: 10.1016/0076-6879(83)01028-9. [DOI] [PubMed] [Google Scholar]
  12. Janknecht R. EWS-ETS oncoproteins: the linchpins of Ewing tumors. Gene. 2005;363:1–14. doi: 10.1016/j.gene.2005.08.007. [DOI] [PubMed] [Google Scholar]
  13. Jones N.C., Richter J.D., Weeks D.L., Smith L.D. Regulation of adenovirus transcription by an E1a gene in microinjected Xenopus laevis oocytes. Mol Cell Biol. 1983;3:2131–2142. doi: 10.1128/MCB.3.12.2131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kim J., Lee J.M., Branton P.E., Pelletier J. Modification of EWS/WT1 functional properties by phosphorylation. Proc Natl Acad Sci U S A. 1999;96:14300–14305. doi: 10.1073/pnas.96.25.14300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kim J., Lee J.M., Branton P.E., Pelletier J. Modulation of EWS/WT1 activity by the v-Src protein tyrosine kinase. FEBS Lett. 2000;474:121–128. doi: 10.1016/S0014-5793(00)01590-8. [DOI] [PubMed] [Google Scholar]
  16. Kim J., Pelletier J. Molecular genetics of chromosome translocations involving EWS and related family members. Physiol Genomics. 1999;1:127–138. doi: 10.1152/physiolgenomics.1999.1.3.127. [DOI] [PubMed] [Google Scholar]
  17. Kovar H., Aryee D., Zoubek A. The Ewing family of tumors and the search for the Achilles’ heel. Curr Opin Oncol. 1999;11:275–284. doi: 10.1097/00001622-199907000-00007. [DOI] [PubMed] [Google Scholar]
  18. Krajewski W., Lee K.A.W. A monomeric derivative of the cellular transcription factor CREB functions as a constitutive activator. Mol Cell Biol. 1994;14:7204–7210. doi: 10.1128/MCB.14.11.7204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Law W.J., Cann K.L., Hicks G.G. TLS, EWS and TAF15: a model for transcriptional integration of gene expression. Brief Funct Genomics Proteomics. 2006;5:8–14. doi: 10.1093/bfgp/ell015. [DOI] [PubMed] [Google Scholar]
  20. Li K.K.C., Lee K.A.W. Transcriptional activation by the Ewing’s sarcoma (EWS) oncogene can be cis-repressed by the EWS RNA-binding domain. J Biol Chem. 2000;275:23053–23058. doi: 10.1074/jbc.M002961200. [DOI] [PubMed] [Google Scholar]
  21. MacArthur H., Walter G. Monoclonal antibodies specific for the carboxy terminus of simian virus 40 large T antigen. J Virol. 1984;52:483–491. doi: 10.1128/jvi.52.2.483-491.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Masson N., Ellis M., Goodbourn S., Lee K.A.W. Cyclic AMP response element-binding protein and the catalytic subunit of protein kinase A are present in F9 embryonal carcinoma cells but are unable to activate the somatostatin promoter. Mol Cell Biol. 1992;12:1096–1106. doi: 10.1128/MCB.12.3.1096. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Ng K.P., Li K.K.C., Lee K.A.W. In vitro activity of the EWS oncogene transcriptional activation domain. Biochemistry. 2009;48:2849–2857. doi: 10.1021/bi802366h. [DOI] [PubMed] [Google Scholar]
  24. Ng K.P., Potikyan G., Savene R.O., Denny C.T., Uversky V.N., Lee K.A.W. Multiple aromatic side chains within a disordered structure are critical for transcription and transforming activity of EWS family oncoproteins. Proc Natl Acad Sci U S A. 2007;104:479–484. doi: 10.1073/pnas.0607007104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Olsen R.J., Hinrichs S.H. Phosphorylation of the EWS IQ domain regulates transcriptional activity of the EWS/ATF1 and EWS/FLI1 fusion proteins. Oncogene. 2001;20:1756–1764. doi: 10.1038/sj.onc.1204268. [DOI] [PubMed] [Google Scholar]
  26. Pan S., Ming K.Y., Dunn T.A., Li K.K.C., Lee K.A.W. The EWS/ATF1 fusion protein contains a dispersed activation domain that functions directly. Oncogene. 1998;16:1625–1631. doi: 10.1038/sj.onc.1201671. [DOI] [PubMed] [Google Scholar]
  27. Prieur A., Tirode F., Cohen P., Delattre O. EWS/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein 3. Mol Cell Biol. 2004;24:7275–7283. doi: 10.1128/MCB.24.16.7275-7283.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Ribeiro A., Brown A.D., Lee K.A.W. An in vivo assay for members of the CREB family of transcription factors. J Biol Chem. 1994;269:31124–31128. [PubMed] [Google Scholar]
  29. Rual J.F., Venkatesan K., Hao T., Hirozane-Kishikawa T., Dricot A., Li N., Berriz G.F., Gibbons F.D., Dreze M., Ayivi-Guedehoussou N., et al. Towards a proteome-scale map of the human protein-protein interaction network. Nature. 2005;437:1173–1178. doi: 10.1038/nature04209. [DOI] [PubMed] [Google Scholar]
  30. Sadowski I., Ptashne M. A vector for expressing GAL4 (1–147) fusions in mammalian cells. Nucleic Acids Res. 1989;17:7539. doi: 10.1093/nar/17.18.7539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Zhou H., Lee K.A.W. An hsRPB4/7-dependent yeast assay for trans-activation by the EWS oncogene. Oncogene. 2001;20:1519–1524. doi: 10.1038/sj.onc.1204135. [DOI] [PubMed] [Google Scholar]
  32. Zucman J., Delattre O., Desmaze C., Epstein A.L., Stenman G., Speleman F., Fletchers C.D.M., Aurias A., Thomas G. EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts. Nat Genet. 1993;4:341–345. doi: 10.1038/ng0893-341. [DOI] [PubMed] [Google Scholar]

Articles from Protein & Cell are provided here courtesy of Oxford University Press

RESOURCES